Genetic Variants and Associations of 25-Hydroxyvitamin D Concentrations With Major Clinical Outcomes
Author(s) -
Gregory P. Levin,
Cassianne RobinsonCohen,
Ian H. de Boer,
Denise K. Houston,
Kurt Lohman,
Yongmei Liu,
Stephen B. Kritchevsky,
Jane A. Cauley,
Toshiko Tanaka,
Luigi Ferrucci,
Stefania Bandinelli,
Kushang V. Patel,
Emil Hagström,
Karl Michaëlsson,
Håkan Melhus,
Thomas J. Wang,
Myles Wolf,
Bruce M. Psaty,
David S. Siscovick,
Bryan Kestenbaum
Publication year - 2012
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2012.17304
Subject(s) - medicine , vitamin d and neurology , context (archaeology) , calcitriol receptor , vitamin d binding protein , prospective cohort study , cohort study , vitamin d deficiency , cohort , endocrinology , biology , paleontology
Lower serum 25-hydroxyvitamin D concentrations are associated with greater risks of many chronic diseases across large, prospective community-based studies. Substrate 25-hydroxyvitamin D must be converted to 1,25-dihydroxyvitamin D for full biological activity, and complex metabolic pathways suggest that interindividual variability in vitamin D metabolism may alter the clinical consequences of measured serum 25-hydroxyvitamin D.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom